April 25, Wednesday

April 26, Thursday

April 27, Friday

April 28, Saturday

April 29, Sunday

April 28, Saturday

  HALL 1 HALL 2 HALL 3 HALL 4 HALL 5 HALL 6
07:00 - 08:30 COURSE 19

Virtual Reality (VR): applications through acceptance and commitment therapy (ACT)
Furkan Bahadır ALPTEKİN
Hüseyin Şehit BURHAN
COURSE 20

Diagnostic challenges, instruments used and pharmacological treatments in schizo-obsessive disorder
Levent SEVİNÇOK
COURSE 21

Mother-infant interaction: a multiaxial assessment (ABEÇED)
Koray KARABEKİROĞLU
ORAL PRESENTATIONS 12

Moderators:
Murat ALTIN (TAP)

SS-103, SS-105, SS-106, SS-107, SS-108, SS-110, SS-112, SS-114, SS-115
ORAL PRESENTATIONS 13

Moderators:
Ömer YANARTAŞ (TAP)

SS-116, SS-117, SS-120, SS-122, SS-123, SS-124, SS-128, SS-129, SS-130
COURSE 22

Same diagnosis, different treatments: introduction to behavioral psyhopharmacology
K. Fatih YAVUZ (TAP)
08:30 - 09:00 BREAKFAST
09:00 - 10:30

JOINT CONFERENCE 2

Insights from Basic and Clinical Research: Treatment Resistance Depression (TRD)

Discussant Moderators:
David OSSER (USA), Serhat ÇITAK (TAP)

Neurobiological basis of TRD: current status and future projections
Feyza ARICIOĞLU (TAP)

Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia as a clinical predictor of effectiveness
Serdar DURSUN (Canada)

CONFERENCE 13

Moderators:
Nursu ÇAKIN MEMİK, Tayyib KADAK

Intersections of cultural formulation and psychotherapy in child and adolescent therapy
Jaswant GUZDER (Canada)

SYMPOSIA ORAL SESSION 28

New Technologies and Applications in Psychiatry

Moderators:
Hasan Turan KARATEPE (TAP), Şengül İLKAY

Virtual reality (VR)
Şengül İLKAY

Telemedicine
Mehmet Emrah KARADERE

Optical coherence tomography (OCT)
Mehmet Hamdi ÖRÜM

Artificial intelligence and its psychiatric use
Ezgi İNCE GULIYEV


SYMPOSIA ORAL SESSION 29

Depression Treatment: Beyond Antidepressants Use?

Discussant Moderators:

Mustafa SOLMAZ (TAP), Servet EBRİNC (TAP)

Any beneficial affects of exercise on depression?
Ayşe SAKALLI KANİ

What are positive/negative affects of nutrition on depression?
Mesut YILDIZ (TAP)

Light therapies in depression treatment
Neşe YORGUNER KÜPELİ

Phytotherapy for depression
Serkut BULUT

COURSE 23

How do we combine psychotherapy and psychopharmacology in treatment?
Hakan TÜRKÇAPAR

 
10:30 - 11:00 COFFEE BREAK
11:00 - 12:30

CONFERENCE 14

Moderator:
Kemal SAYAR (TAP)

Psychopathology and cognitive neuroscience- the example of delusional misidentification syndromes
Femi OYEBODE (UK)

SYMPOSIA ORAL SESSION 30

How Can We Overcome Treatment Resistence in Schiophrenia? Is Clozapine Fear Justifiable or Exaggerated? Principles of Clozapine Treatment in Stages and Psychosocial Approaches in Overcoming Treatment Resistence

Moderators:
Rüstem AŞKIN, Mesut ÇETİN (TAP)

Before starting clozapine
Hüseyin GÜLEÇ

While starting clozapine
Şakir GICA

After starting clozapine
Salime GÜRSOY

Psychotherapy and psychosocial treatments in scizophrenia
Köksal ALPTEKİN

CONFERENCE 15

Moderators:
Bengi SEMERCİ (TAP), Umut Mert AKSOY (TAP)

Effects of stimulant treatment in adult ADHD: from symptom reduction to functional improvement
Wolfgang RETZ (Germany)

SYMPOSIA ORAL SESSION 31

Resilience from All Aspects

Discussant Moderators:
Yasemen IŞIK, Kemal Utku YAZICI

Child psychiatrist’s view of resilience
Özlem ÖZEL ÖZCAN

Biological aspects of resilience beyond genetics
Hale YAPICI ESER

How can we increase resilience in children and adolescents?
Didem ÖZTOP

Distinct psychopathologies and their relationships with domains of resilience
Ali Evren TUFAN (TAP)

SYMPOSIA ORAL SESSION 32

Unique Approaches to Patients with Epilepsy and Collaboration in the Management

Moderators:
Çiçek HOCAOĞLU, Esra YAZICI

Up-to-date commonly used medications in the treatment of epilepsy
Figen YAVLALI

Depression and anxiety Disorders in patients with epilepsy
Gamze ERGİL ALTIN (TAP)

Treatment of depression and anxiety disorders in patients with epilepsy
Murat ALTIN (TAP)

Treatment of drug addiction in patients with epilepsy
Burak TOPRAK

 
12:30 - 13:30 LUNCH
13:30 - 15:00

CONFERENCE 16

Moderators:
Birim GÜNAY KILIÇ, Didem ÖZTOP

Intervention in early onset psychosis
Maite FERRIN (UK)

SYMPOSIA ORAL SESSION 33

New Waves of Psychotherapies and Their Status in Turkey

Moderator:
Kazım YAZICI (TAP)

What does psychodynamic psychotherapy promise us?
Serhat ÇITAK (TAP)

New waves of cognitive and behavioral therapy (CBT)
M. Hakan TÜRKÇAPAR (TAP)

What is the current status of psychotherapies in Turkey?
Erol GÖKA (TAP)

An integrative approach to psychotherapies
Kemal SAYAR (TAP)

SYMPOSIA ORAL SESSION 34

Bipolar disorder with comorbid anxiety disorders

Moderators:
Levent SEVİNÇOK, David OSSER (USA)

Prevalence of comorbid anxiety disorders in bipolar disorder
Merve YALÇINAY İNAN

Determinants of comorbid anxiety disorders in bipolar disorder
Anıl Şafak KAÇAR

Neurobiology and treatment of comorbid anxiety disorders in bipolar disorder
Hale YAPICI ESER

SYMPOSIA ORAL SESSION 35

Recent Evidences in the Etiology of Autism and Attention-Deficit/ Hyperactivity Disorder: How Influential Are Environmental Factors in the Etiology and Treatment of ADHD?

Discussant Moderators:
Ebru ÇENGEL KÜLTÜR, Esengül KAYAN

What does current literature tell us for the etiology of ADHD?
Umut Mert AKSOY (TAP)

What does current literature tell us for the etiology of autism?
Tayyib KADAK

Review of evidence-based approaches on environmental and other factors in ADHD and autism
M. Cem TARAKÇIOĞLU (TAP)

Can we develop different hypotheses for neurodevelopmental disorders?
Hasan ÖNAL

COURSE 24

Brain Gut Microbiota Axis: Psychobiotics and Mental Health


Moderators:

Mesut YILDIZ (TAP), Murat ALTIN (TAP)

Gastrointestinal symptoms in mental disorders
Ali Emre ŞEVİK

A novel approach for understanding mental disorders: brain-gut axis
Serhat ERGUN (TAP)

Psychobiotics and their usage in mental disorders
Emel KURT

Microbiota: a novel therapeutic target for mental disorders
Ömer YANARTAŞ (TAP)

 
15:00 - 15:30 COFFEE BREAK
15:30 - 17:00

JOINT CONFERENCE 3

Neuroimaging Studies in Psychiatry: An Update

Moderator:
Xin Min LI (Canada)


Neuroimaging evidence for white matter pathology across schizophrenia course and its terapeutic implications
Marek KUBICKI (USA)

How do sexual traumas make changes in the brains of adolescents?
Ali Saffet GÖNÜL (TAP)

SYMPOSIA ORAL SESSION 36

Theory of Mind and Its Applications in Children

Discussant Moderators:
Özlem YILDIZ, Ayhan BİLGİÇ

Development and neurobiology of nheory of mind
Abdullah BOZKURT

Theory of mind in children and psychopathology
Berkan ŞAHİN

Mind-based treatments
Saliha BAYKAL

Theory of mind: division of the internal and external world
Koray KARABEKİROĞLU

SYMPOSIA ORAL SESSION 37

Obsessive Compulsive Disorder in Children and Adolescents

Discussant Moderators:
Nursu ÇAKIN MEMİK, Fatih CEYLAN

Novel approaches in neurobiology of obsessive compulsive disorder: where is glutamate in the OCD brain?
İpek PERÇİNEL YAZICI

Can we identify Obsessive Compulsive Disorder adequately? Problems in diagnosis
İlknur UCUZ

Where do we stand on the pharmacological treatment of resistant Obsessive Compulsive Disorder? Novel alternatives
Kemal Utku YAZICI

Revisiting the Obsessive Compulsive Disorder from a psychotherapeutic framework
Özlem ÖZEL ÖZCAN


SYMPOSIA ORAL SESSION 38

Post-traumatic Stress Disorder and Appraches in Its Management

Moderator:
Cem CERİT

Clinical manifestations of post-traumatic stress disorder
Feyza ÇELİK

Up-to-date psychopharmacological treatments in post-traumatic stress disorder
Esma AKPINAR ASLAN

Psychotherapies in post-traumatic stress disorder
Sedat BATMAZ

ORAL PRESENTATIONS 14

Moderators:
Murat ALTIN (TAP), Ömer YANARTAŞ (TAP)

SS-038, SS-057, SS-064, SS-089, SS-127, SS-131, SS-137, SS-140
 
17:30 - 19:00

SYMPOSIA ORAL SESSION 39

Rational Versus Irrational Drug Use

Discussant Moderators:
Rüstem AŞKIN, Bengi SEMERCİ (TAP)

Economical costs
Mesil AKSOY (TR Ministry of Health, Director of Rational Drug Use Department)

Educating primary care physicians in rational drug use
Rüstem AŞKIN

Serious consequences of drug-drug interactions
Mesut ÇETİN (TAP)

SYMPOSIA ORAL SESSION 40

A Different View of Child Psychopharmacology

Moderators:
Tayyib KADAK, Ömer Faruk AKÇA

Do we use psychopharmacological agents in children appropriately or over-use them?
Dursun KARAMAN

Differences in psychopharmacology of pediatric bipolar disorder and adult bipolar disorder
Halil KARA

Differences in psychopharmacology of pediatric schizophrenia and adult schizophrenia
Özge DEMİRCAN TULACI

Mechanisms of molecular efficacy of psychostimulants in ADHD
Şahin BODUR

SYMPOSIA ORAL SESSION 41

Psychopharmacological Treatments in Autistic Spectrum Disorders (ASD)

Discussant Moderators:
Işık GÖRKER, Burak DOĞANGÜN

Use of antipsychotics in children and adolescents with ASD
Selma TURAL HESAPÇIOĞLU

Psychopharmacological treatment of attention-deficit/ hyperactivity disorder comorbidity in ASD
Gülser ŞENSES DİNÇ

Use of SSRIs and other psychotropics in ASD
Tülin FİDAN

Problematic sexual behaviors and their treatment in children and adolescents with ASD and intellectual disability
Mehmet Fatih CEYLAN

SYMPOSIA ORAL SESSION 42

Substance Use Disorders and Sleep Disturbances

Moderators:
Çiçek HOCAOĞLU, Servet EBRİNÇ (TAP)

Substance use disorders and sleep
Kader Semra KARATAŞ

Substance use disorders and phytotherapy
Bülent BAHÇECİ

Substance use disorders in children and adolescents and sleep disturbances
Murat KAÇAR

SYMPOSIA ORAL SESSION 43

A Clinical Approach to Impulsivity

Moderators:
Levent SEVİNÇOK, Murat DEMET

Impulsivity in impulse control disorders and other psychiatric disorders
Murat ALTIN (TAP)

Impulsivity in children and adolescents
Esengül KAYAN

Impulsivity during pregnancy and postpartum period
Gamze ERGİL ALTIN (TAP)

 

20:00 - 21:30 AWARDS CEREMONY